4.6.1. Detection of NF-κB p65 Subunit Nuclear Translocation

ZF Zsolt Fejes
MP Marianna Pócsi
JT Jun Takai
JE Judit Erdei
AT Andrea Tóth
EB Enikő Balogh
ÁR Ágnes Rusznyák
FF Ferenc Fenyvesi
AN Andrea Nagy
JK János Kappelmayer
VJ Viktória Jeney
BJ Béla Nagy, Jr.
request Request a Protocol
ask Ask a question
Favorite

The NF-κB pathway activation (p65 nuclear translocation) in HCPEpiC cultures was visualized via p65 nuclear immunofluorescence staining based on the method drawn from our previous study [38] with some minor modifications. For this purpose, HCPEpiCs were cultured in BioLite 24-well plates (Thermo Scientific) on sterile glass microscope slides at a density of 5 × 104 cells/slide. Cells were then treated with IVH-III, IVH-IV, or non-IVH control CSF samples (10 v/v %) for 1 h. After treatment, cells were washed twice with DPBS solution and fixed with ice-cold methanol-acetone (50 v/v %, Sigma-Aldrich, St. Louis, MO, USA) for 10 min. Non-specific antibody binding sites were blocked with FBS (Sigma-Aldrich) for 15 min. For primary labeling of the NF-κB p65 subunit, a polyclonal rabbit anti-human p65 antibody (100 μg/mL, sc-372, Santa Cruz Biotechnology, Dallas, TX, USA) was used for 1 h, followed by secondary staining with Alexa Fluor 488-conjugated goat-anti-rabbit IgG (5 μg/mL, A32731, Invitrogen, Carlsbad, CA, USA) for 1 h. Cell nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen) and samples were observed by Zeiss Axio Scope A1 fluorescent microscope (HBO 100 lamp) (Carl Zeiss Microimaging GmbH, Goettingen, Germany); DAPI: excitation at 365 nm and emission BP filter 445/50 nm; and fluorescein: excitation of BP filter at 470/40 nm and emission BP filter 525/50 nm. Images were analyzed with ZEN 2012 v.1.1.0.0. software (Carl Zeiss Microimaging GmbH). The ratio of nuclear and cytosol fluorescence intensity was calculated for NF-κB p65 staining. The specificity of immunostaining was checked by incubating the cells with the secondary antibody alone and only a limited background staining was seen.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A